Florent Joly

495 total citations
19 papers, 230 citations indexed

About

Florent Joly is a scholar working on Nephrology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Florent Joly has authored 19 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 7 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Florent Joly's work include Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Dialysis and Renal Disease Management (4 papers) and Renal Diseases and Glomerulopathies (3 papers). Florent Joly is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Dialysis and Renal Disease Management (4 papers) and Renal Diseases and Glomerulopathies (3 papers). Florent Joly collaborates with scholars based in France, United States and United Kingdom. Florent Joly's co-authors include Frank Bridoux, Mohamed Belmouaz, Marc Bauwens, P Jamet, Thierry Hauet, Elise Gand, Camille Cohen, Christophe Sirac, Vincent Javaugue and Guy Touchard and has published in prestigious journals such as Blood, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Florent Joly

17 papers receiving 225 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florent Joly France 8 124 90 50 49 40 19 230
Katarzyna Krzanowska Poland 9 56 0.5× 51 0.6× 34 0.7× 49 1.0× 20 0.5× 39 229
Donata Cresseri Italy 10 190 1.5× 18 0.2× 57 1.1× 66 1.3× 19 0.5× 40 356
Saoussen Krid France 7 227 1.8× 22 0.2× 54 1.1× 53 1.1× 47 1.2× 23 372
Francesca Brunini Italy 9 91 0.7× 62 0.7× 51 1.0× 11 0.2× 24 0.6× 12 297
Chiara Donadei Italy 9 67 0.5× 25 0.3× 46 0.9× 50 1.0× 17 0.4× 21 243
Andromachi Mitsioni Greece 10 141 1.1× 60 0.7× 24 0.5× 26 0.5× 19 0.5× 26 220
Masaki Muramatsu Japan 11 104 0.8× 41 0.5× 134 2.7× 31 0.6× 10 0.3× 61 357
Opas Traitanon Thailand 11 107 0.9× 27 0.3× 49 1.0× 16 0.3× 11 0.3× 21 343
Alison Lap‐tak China 10 220 1.8× 26 0.3× 26 0.5× 38 0.8× 41 1.0× 36 323
S C Dash India 9 151 1.2× 66 0.7× 51 1.0× 21 0.4× 40 1.0× 25 279

Countries citing papers authored by Florent Joly

Since Specialization
Citations

This map shows the geographic impact of Florent Joly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florent Joly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florent Joly more than expected).

Fields of papers citing papers by Florent Joly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florent Joly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florent Joly. The network helps show where Florent Joly may publish in the future.

Co-authorship network of co-authors of Florent Joly

This figure shows the co-authorship network connecting the top 25 collaborators of Florent Joly. A scholar is included among the top collaborators of Florent Joly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florent Joly. Florent Joly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Belmouaz, Mohamed, Florent Joly, Éstelle Desport, et al.. (2025). Effects of super high-flux vitamin E–coated and medium cut-off dialyzers on uremic toxins removal and biocompatibility: the E-FLUX randomized controlled study. Clinical Kidney Journal. 18(5). sfaf106–sfaf106.
2.
Belmouaz, Mohamed, Florent Joly, Cécile Martin, et al.. (2022). Comparison of High-Flux, Super High-Flux, Medium Cut-Off Hemodialysis and Online Hemodiafiltration on the Removal of Uremic Toxins. Blood Purification. 52(3). 309–318. 8 indexed citations
3.
Belmouaz, Mohamed, Florent Joly, Laure Écotière, et al.. (2022). Comparison of the injection of low‐molecular weight heparin in the arterial vs. venous blood line for preventing extracorporeal circuit clotting during hemodialysis. Hemodialysis International. 26(3). 314–322. 2 indexed citations
4.
Belmouaz, Mohamed, et al.. (2022). Comparison of High-Flux, Super High-Flux, Medium Cut-Off Hemodialysis and Online Hemodiafiltration on the Removal of Uremic Toxins. Journal of the American Society of Nephrology. 33(11S). 717–717. 1 indexed citations
5.
Bridoux, Frank, Paul Cockwell, Ilya Glezerman, et al.. (2021). Kidney injury and disease in patients with haematological malignancies. Nature Reviews Nephrology. 17(6). 386–401. 22 indexed citations
6.
Said, Samar M., Anthony M. Valeri, Paisit Paueksakon, et al.. (2021). The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis. Kidney International. 101(1). 152–163. 6 indexed citations
7.
Coudroy, Rémi, Maeva Rodriguez, Florent Joly, et al.. (2021). High risk of pulmonary embolism in acute respiratory distress syndrome related to COVID-19: an observational controlled-cohort study. Annals of Translational Medicine. 9(8). 630–630. 4 indexed citations
8.
Cohen, Camille, Florent Joly, Vincent Javaugue, et al.. (2021). Randall-Type Monoclonal Immunoglobulin Deposition Disease: New Insights into the Pathogenesis, Diagnosis and Management. Diagnostics. 11(3). 420–420. 4 indexed citations
9.
Milani, Paolo, Nelson Leung, Efstathios Kastritis, et al.. (2020). Light Chain Deposition Disease: First Analysis of an International Study in 359 Patients. Blood. 136(Supplement 1). 33–34. 1 indexed citations
10.
Joly, Florent, Bruno Degand, Claire Bouleti, et al.. (2020). Randall-type monoclonal immunoglobulin deposition disease: description of cardiac involvement. European Heart Journal. 41(Supplement_2).
11.
Frat, Jean‐Pierre, Florent Joly, & Arnaud W. Thille. (2019). Noninvasive ventilation versus oxygen therapy in patients with acute respiratory failure. Current Opinion in Anaesthesiology. 32(2). 150–155. 6 indexed citations
12.
Belmouaz, Mohamed, Marc Bauwens, Thierry Hauet, et al.. (2019). Comparison of the removal of uraemic toxins with medium cut-off and high-flux dialysers: a randomized clinical trial. Nephrology Dialysis Transplantation. 35(2). 328–335. 65 indexed citations
13.
Robert, René, Denis Frasca, Bertrand Souweine, et al.. (2018). Histologically proven acute tubular necrosis in a series of 27 ICU patients. Journal of Critical Care. 48. 130–134. 2 indexed citations
14.
Joly, Florent, Camille Cohen, Vincent Javaugue, et al.. (2018). Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study. Blood. 133(6). 576–587. 69 indexed citations
15.
Cohen, Camille, Vincent Javaugue, Florent Joly, et al.. (2016). Maladie de dépôts d’immunoglobulines monoclonales de type Randall : du diagnostic au traitement. Néphrologie & Thérapeutique. 12(3). 131–139. 9 indexed citations
16.
Noal, Sabine, Florent Joly, & Éric Leblanc. (2010). Prise en charge d’une tumeur trophoblastique gestationnelle. Gynécologie Obstétrique & Fertilité. 38(3). 193–198. 9 indexed citations
17.
Dray, Xavier, Xavier Tréton, Florent Joly, et al.. (2006). Hemorrhagic bullous colitis as a primary manifestation of AL amyloidosis. Endoscopy. 38(S 2). E15–E16. 9 indexed citations
18.
Lavergne‐Slove, Anne, et al.. (1999). [Isolated jejunal tuberculosis mimicking Crohn disease. Diagnosis by push video-enteroscopy].. PubMed. 23(10). 1086–9. 5 indexed citations
19.
Pradinaud, R., et al.. (1971). [Chromomycosis and Jorge Lobo disease in French Guiana].. PubMed. 62(6). 1054–63. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katarzyna Krzanowska Breakdown of academic impact, for papers by Donata Cresseri Breakdown of academic impact, for papers by Saoussen Krid Breakdown of academic impact, for papers by Francesca Brunini Breakdown of academic impact, for papers by Chiara Donadei Breakdown of academic impact, for papers by Andromachi Mitsioni Breakdown of academic impact, for papers by Masaki Muramatsu Breakdown of academic impact, for papers by Opas Traitanon Breakdown of academic impact, for papers by Alison Lap‐tak Breakdown of academic impact, for papers by S C Dash
Rankless by CCL
2026